Myriad Genetics Files 8-K with Key Agreements and Obligations
Ticker: MYGN · Form: 8-K · Filed: Jul 31, 2025 · CIK: 899923
| Field | Detail |
|---|---|
| Company | Myriad Genetics Inc (MYGN) |
| Form Type | 8-K |
| Filed Date | Jul 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-obligation, corporate-action
Related Tickers: MYGN
TL;DR
MYGN filed an 8-K on 7/31/25 - material agreements & financial obligations disclosed.
AI Summary
On July 31, 2025, Myriad Genetics, Inc. filed an 8-K report detailing several key events. These include entering into a material definitive agreement, creating a direct financial obligation, and other significant events. The filing also includes financial statements and exhibits.
Why It Matters
This filing indicates significant corporate actions and potential financial commitments for Myriad Genetics, which could impact its operational and financial standing.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and financial obligations, which inherently carry risks that could affect the company's financial health and operations.
Key Players & Entities
- MYRIAD GENETICS INC (company) — Registrant
- July 31, 2025 (date) — Date of earliest event reported
- 0000899923-25-000072 (document_id) — Accession Number
FAQ
What specific material definitive agreement did Myriad Genetics enter into?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in this summary section of the 8-K.
What is the nature of the direct financial obligation or off-balance sheet arrangement?
The filing states that a direct financial obligation or an obligation under an off-balance sheet arrangement of a registrant was created, but the specifics are not detailed here.
What other events are reported in this 8-K filing?
Besides the material agreement and financial obligation, the filing also reports 'Other Events' and 'Financial Statements and Exhibits'.
When was this 8-K report filed?
The report was filed as of July 31, 2025.
What is Myriad Genetics' principal executive office address?
Myriad Genetics' principal executive offices are located at 322 North 2200 West, Salt Lake City, Utah 84116.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 31, 2025 regarding MYRIAD GENETICS INC (MYGN).